Company intelligence / Profile preview

Syngoi Technologies

Zamudio/Bilbao/Derio area, Basque Country/Bizkaia, Spainsyngoi.com ↗

Ownership: Private
Development stage: Commercial

Overview

Syngoi Technologies is an active biotechnology CDMO specializing in the custom manufacture of high-purity, linear synthetic DNA using a proprietary cell-free enzymatic process. Their technology enables rapid, scalable, and bacteria/antibiotic-resistance-gene-free production of GMP-grade DNA suitable for advanced therapies such as gene therapy and mRNA vaccines. They have expanded their manufacturing capacity following recent investment rounds to meet growing demand in the sector.

Modalities: Synthetic DNALinear DNA constructs
Industry: Contract Manufacturing Organization

Partnerships

Columbus Venture PartnersAsahi Kasei Medical

Beyond the preview

Go deeper on Syngoi Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syngoi Technologies.

Explore the full profile